"○インフルエンザ予防接種 【料金: 1回目3,500円 2回目2,500円】 (年齢に関わらず、一律です。さいたま市協力機関ではありませんので高齢の方も3,500円です。) ・皮膚科診察をしたことがない方も接種可能です。 ・予約制ではございません。来ていただいた順番にご案内いたします。 ・予防接種のみの場合、保険証と診察券は不要です。 詳しくはマップ上の最新情報をご覧ください。 ○皮膚科の診察 ・当院は予約制ではございません。予約はできかねます。 ・診療時間内に保険証をお持ちいただければ順番にご案内できます。 ・以前来院された方は診察券もお持ちください。"

During the past decade, Sanrui Hifuka conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sanrui Hifuka" are "Dermatitis, Atopic" (3 trials), "Dermatitis" (1 trials), "Eczema" (1 trials), "Genetic Diseases, Inborn" (1 trials) and "Hypersensitivity" (1 trials). Many other conditions were trialed in "Sanrui Hifuka" in a lesser frequency.

Most popular intervention types in "Sanrui Hifuka" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanrui Hifuka" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Sanrui Hifuka". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sanrui Hifuka, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sanrui Hifuka, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".